Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Comment by CUR2004on Sep 07, 2011 4:12pm
246 Views
Post# 19019457

RE: RE: NEW PCA3 WEB SITE

RE: RE: NEW PCA3 WEB SITE

From Diagnocure website:

Canadian laboratories

The following laboratories offer Gen-Probe's PCA3 test.

From Q2 2010 of Warnex

Bioanalytical revenues are growing this year due, we hope, to the end of the recession. Medical is more influenced by regular organic growth especially higher market penetration of the PCA3 diagnostic test.”



I don't know if they sale the Progensa Pca3 test or their home test, since Gen-Probe obtain approval in Canada.

Bullboard Posts